1[3]Mulder TJP,Manni JJ,Raclofs HIKI,et al.GluathioneS-Strasferasea andglutafthine in human head and neck cancer[J].Careinogenesis,1995,16:619～624.
2[4]Stathopoulos GP,Kapranos N,Manolopoulos L et al.Topoisomeras llalpha expression in squamous cell carcinomas of the head and neck[J].Anticancer Res,2000,20(1A):177～182.
3[6]CortesinaG,StefaniAD,GaleazziE,et al.Temporaryre-gression of recurrent squamous cell carcinoma of the head and neck 15 achieved with a low but not with a hish dose of recomhionant interleukin 2 injected perilymphaieally[J].Br J Cancer,1994,69:572.
4[7]Ling V,Thompson L.Reduced permeabihty in CHO cellsas a mechanism of resistance to colehicine[J].J Cell Physiol,1974,83:103.
5[8]Aurora COSTA,Lisa L1CITRA,et al.Biolgieal markers as indicators of patholo-gyieal response to primary chemotherapy in oral-cavity cancdrs[J].Int J Cancer,1998,79:619～623.
6[9]Venemni S,Silvestrini,et al.Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx.Eump[J].J.Cancer Oral OnoL 1997,33:408-413.
7[10]Witlloff S,Jong Des,Vries De EG,et al.Humanal DNA Topoisomerase:biochemistry and role in chemotherapy resistante[J].Ant-I-cancer Res,19916,16(4a):1867.
8[11]Stathopoulos GP,Kapranos N,Manolopoulos L,et al.Topoisomerasc 11alpha expression in squamous cell carcinomas of the head and neck[J].Anticaneer Res,2000,20(IA):177～182.
